001     272829
005     20240918113033.0
024 7 _ |a 10.1007/s11248-023-00336-y
|2 doi
024 7 _ |a pmid:36826606
|2 pmid
024 7 _ |a 0962-8819
|2 ISSN
024 7 _ |a 1573-9368
|2 ISSN
024 7 _ |a altmetric:142880868
|2 altmetric
037 _ _ |a DKFZ-2023-00402
041 _ _ |a English
082 _ _ |a 590
100 1 _ |a Wang, Shubei
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Transgenic HPV11-E2 protein modulates URR activity in vivo.
260 _ _ |a London
|c 2023
|b Chapman & Hall
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726651804_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:W430#LA:W430# / 2023 Apr;32(1-2):67-76 / Cryopreservation W430
520 _ _ |a In vitro experiments have shown that the E2 protein of human papillomaviruses (HPV) binds to the upstream regulatory region (URR) of the viral genome and modulates transcription. Additionally, it seems to be a necessary component for viral DNA replication together with E1. We have developed a transgenic mouse model containing the URR region of the low-risk virus HPV11 that regulates the expression of the lacZ reporter gene. Most interestingly, in these mice, the transgene was exclusively expressed in the bulge region of the hair follicle but not in any other tissues. Further experimental data indicate that in double transgenic mice that also express the HPV11-E2 protein under the control of the Ubiquitin C-promoter, the transcription of the reporter gene is modulated. When E2 is present, the expression of the reporter gene also occurs exclusively in the bulge region of the hair follicles as it does in the single transgenic mice, but the expression of the lacZ driven by the URR is increased and the statistical spread is greater. Even if the expression of the reporter gene occurs in the hair follicles of the dorsal skin of an animal uniform, E2 obviously has the capacity for both to induce and to repress the URR activity in vivo.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a HPV-E2
|2 Other
650 _ 7 |a Human papillomavirus type 11
|2 Other
650 _ 7 |a Reporter gene
|2 Other
650 _ 7 |a Transgenic mouse model
|2 Other
650 _ 7 |a Upstream regulatory region URR
|2 Other
700 1 _ |a Gramm, Vera
|0 P:(DE-He78)3a2ebf39768b8fe8dd25965b08873104
|b 1
|e First author
700 1 _ |a Laport, Elke
|0 P:(DE-He78)26b012bbbc85e8736a8979469a69d9f6
|b 2
|u dkfz
700 1 _ |a Holland-Letz, Tim
|0 P:(DE-He78)457c042884c901eb0a02c18bb1d30103
|b 3
|u dkfz
700 1 _ |a Alonso, Angel
|0 P:(DE-He78)0e9c7f8ab141d513965e8f2237a716b7
|b 4
700 1 _ |a Schenkel, Johannes
|0 P:(DE-He78)1b0532fc51fd835d3bb64196e6e751fc
|b 5
|e Last author
|u dkfz
773 _ _ |a 10.1007/s11248-023-00336-y
|0 PERI:(DE-600)1498785-5
|n 1-2
|p 67-76
|t Transgenic research
|v 32
|y 2023
|x 0962-8819
909 C O |p VDB
|o oai:inrepo02.dkfz.de:272829
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)3a2ebf39768b8fe8dd25965b08873104
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)26b012bbbc85e8736a8979469a69d9f6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)457c042884c901eb0a02c18bb1d30103
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)0e9c7f8ab141d513965e8f2237a716b7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)1b0532fc51fd835d3bb64196e6e751fc
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2023
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b TRANSGENIC RES : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-25
920 2 _ |0 I:(DE-He78)W430-20160331
|k W430
|l Gruppe Schenkel
|x 0
920 1 _ |0 I:(DE-He78)W430-20160331
|k W430
|l Gruppe Schenkel
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 1
920 1 _ |0 I:(DE-He78)F050-20160331
|k F050
|l Zelldifferenzierung
|x 2
920 0 _ |0 I:(DE-He78)W430-20160331
|k W430
|l Gruppe Schenkel
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)W430-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)F050-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21